Drugs / SCH708980
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01437020 | — | immunotherapy induced hypophysitis, visceral leishmaniasis | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCH708980 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01437020 ↗ |
| Action | Inhibit | “anti-IL-10 monoclonal antibody” NCT01437020 ↗ |
| Modality | Monoclonal antibody | “Anti-IL-10 Monoclonal Antibody” NCT01437020 ↗ |
| Route | Intravenous | “a single intravenous (IV) infusion of SCH708980” NCT01437020 ↗ |
| Target | IL10 | “anti-IL-10 monoclonal antibody” NCT01437020 ↗ |